Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
AMGN Amgen
- 291.160
- -3.430-1.16%
Close Feb 14 16:00 ET
- 291.250
- +0.090+0.03%
Post 20:01 ET
156.41BMarket Cap38.51P/E (TTM)
295.162High290.450Low2.19MVolume294.750Open294.590Pre Close639.37MTurnover0.41%Turnover Ratio38.51P/E (Static)537.20MShares338.97352wk High26.61P/B156.01BFloat Cap251.26952wk Low9.00Dividend TTM535.83MShs Float338.973Historical High3.09%Div YieldTTM1.60%Amplitude7.824Historical Low292.033Avg Price1Lot Size
About Amgen Company
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Company Profile
SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees28000
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com
Company Executives
- Name
- Position
- Salary
- Robert A. Bradway
- Chairman of the Board, President and Chief Executive Officer
- 22.64M
- Nancy A. Grygiel
- Senior Vice President and Chief Compliance Officer
- --
- Peter H. Griffith
- Executive Vice President and Chief Financial Officer
- 6.02M
- Matthew C. Busch
- Vice President, Finance and Chief Accounting Officer
- --
- Dr. James E. Bradner, M.D.
- Executive Vice President, Research and Development and Chief Scientific Officer
- --
- Dr. David M. Reese, M.D.
- Executive Vice President and Chief Technology Officer
- 7.90M
- Esteban Santos
- Executive Vice President, Operations
- 7.21M
- Derek Miller
- Senior Vice President, Human Resources
- --
- Rachna Khosla
- Senior Vice President, Business Development
- --
- Jonathan P. Graham
- Executive Vice President, General Counsel and Secretary
- --
- Murdo Gordon
- Executive Vice President, Global Commercial Operations
- 8.24M
- Charles M. Holley, Jr
- Independent Director
- 369.92K
- Dr. Robert Sanders Willia M.D.
- Independent Director
- 360.86K
- Dr. Ronald D. Sugar
- Independent Director
- 379.92K
- Professor Dr. Tyler E. Jacks, PhD
- Independent Director
- 339.92K
- Amy E. Miles
- Independent Director
- 359.92K
- Dr. S. Omar Ishrak
- Independent Director
- 366.47K
- Robert A. Eckert
- Lead Independent Director
- 419.92K
- Michael V. Drake
- Independent Director
- 339.92K
- Mary E. Klotman
- Independent Director
- --
- Greg C. Garland
- Independent Director
- 379.92K
- Ellen J. Kullman
- Independent Director
- 360.29K
- Dr. Wanda M. Austin
- Independent Director
- 359.92K
- Dr. Brian J. Druker, M.D.
- Independent Director
- 359.92K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
